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Background: Cheyne-Stokes respiration (CSR) associated with central sleep apnea deteriorates the prognosis of patients with heart failure (HF). 
However, it still remains unclear whether adaptive servo ventilation (ASV) improves cardiac function and prognosis of patients with HF and CSR. 
Methods: Thirty patients with HF and CSR (mean age 56.6±14.2 years, all males, mean ejection fraction 38.0±16.3%, mean apnea hypopnea 
index 38.3±16.5 times/hr, mean central apnea index 23.1±14.1 times/hr) were enrolled in this study and divided into 2 groups: 15 patients treated 
with conventional medications for HF and ASV (ASV group) and 15 patients treated by conventional medications without ASV (Non-ASV group). 
Plasma B-type natriuretic peptide (BNP) levels, left ventricular ejection fraction (LVEF), LV mass index (LVMI) and left atrial volume index (LAVI) were 
determined before and six months after treatments in each group. Patients were followed up for cardiac events after discharge (rehospitalization 
and cardiac death). 
Results: In ASV group, BNP (P<0.01), LVEF (P<0.05), LVMI (P<0.05) and LAVI (P<0.05) significantly improved after six months with ASV treatment. 
In contrast, any of these parameters did not change in Non-ASV group. Event free rate tended to be higher in ASV group, but this was not statistically 
significant (Logrank P=0.11, mean follow up period 345 days). 
Conclusions: Adaptive servo ventilation improved cardiac function, but not prognosis in this short-term observation.
